Shengtai Pharmaceutical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $
- Today's High:
- $
- Open Price:
- $
- 52W Low:
- $0
- 52W High:
- $0.03
- Prev. Close:
- $0.025
- Volume:
- 507
Company Statistics
- Market Cap.:
- $1.92 million
- Book Value:
- 6.575
- Revenue TTM:
- $221.39 million
- Operating Margin TTM:
- 2.59%
- Gross Profit TTM:
- $18.92 million
- Profit Margin:
- -0.7%
- Return on Assets TTM:
- 1.6%
- Return on Equity TTM:
- -2.42%
Company Profile
Shengtai Pharmaceutical Inc had its IPO on under the ticker symbol SGTI.
The company operates in the sector and industry. Shengtai Pharmaceutical Inc has a staff strength of 0 employees.
Stock update
Shares of Shengtai Pharmaceutical Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0 - $0, and closed at $0.
This is a -20% slip from the previous day's closing price.
A total volume of 507 shares were traded at the close of the day’s session.
In the last one week, shares of Shengtai Pharmaceutical Inc have slipped by -33.33%.
Shengtai Pharmaceutical Inc's Key Ratios
Shengtai Pharmaceutical Inc has a market cap of $1.92 million, indicating a price to book ratio of 0.0298 and a price to sales ratio of 0.0088.
In the last 12-months Shengtai Pharmaceutical Inc’s revenue was $221.39 million with a gross profit of $18.92 million and an EBITDA of $15.96 million. The EBITDA ratio measures Shengtai Pharmaceutical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Shengtai Pharmaceutical Inc’s operating margin was 2.59% while its return on assets stood at 1.6% with a return of equity of -2.42%.
In Q2, Shengtai Pharmaceutical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0.5%.
Shengtai Pharmaceutical Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shengtai Pharmaceutical Inc’s profitability.
Shengtai Pharmaceutical Inc stock is trading at a EV to sales ratio of 0.3866 and a EV to EBITDA ratio of 5.0847. Its price to sales ratio in the trailing 12-months stood at 0.0088.
Shengtai Pharmaceutical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $265.77 million
- Total Liabilities
- $202.75 million
- Operating Cash Flow
- $-630920.00
- Capital Expenditure
- $633815
- Dividend Payout Ratio
- 0%
Shengtai Pharmaceutical Inc ended 2024 with $265.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $265.77 million while shareholder equity stood at $63.02 million.
Shengtai Pharmaceutical Inc ended 2024 with $0.00 in deferred long-term liabilities, $202.75 million in other current liabilities, 9585.00 in common stock, $30.31 million in retained earnings and $0.00 in goodwill. Its cash balance stood at $38.10 million and cash and short-term investments were $0.00. The company’s total short-term debt was $0 while long-term debt stood at $0.00.
Shengtai Pharmaceutical Inc’s total current assets stands at $168.19 million while long-term investments were $14.61 million and short-term investments were $0.00. Its net receivables were $46.30 million compared to accounts payable of $8.84 million and inventory worth $52.98 million.
In 2024, Shengtai Pharmaceutical Inc's operating cash flow was $-630920.00 while its capital expenditure stood at $633815.
Comparatively, Shengtai Pharmaceutical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0
- 52-Week High
- $0.03
- 52-Week Low
- $0
- Analyst Target Price
- $
Shengtai Pharmaceutical Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.03 and a 52-week low of $0.03. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.03 and 200-day moving average was $0.03 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Shengtai Pharmaceutical Inc
Most Active
Top Gainers
Top Losers
About
Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People’s Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment. The company markets its products directly to healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies. Shengtai Pharmaceutical, Inc. was incorporated in 2004 and is based in Weifang, China.